These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33810883)

  • 1. The interest of fluticasone nasal spray in COVID-19 related anosmia is still not demonstrated.
    Lechien JR; Hoch CC; Vaira LA; Saussez S
    Am J Otolaryngol; 2021; 42(4):103008. PubMed ID: 33810883
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor regarding "The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients".
    Verma RR; Gupta N; Singh M
    Am J Otolaryngol; 2021; 42(5):103103. PubMed ID: 34116850
    [No Abstract]   [Full Text] [Related]  

  • 3. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S
    Am J Otolaryngol; 2021; 42(3):102892. PubMed ID: 33493729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients.
    Singh CV; Jain S; Parveen S; Deshmukh P
    Am J Otolaryngol; 2021; 42(4):103009. PubMed ID: 33846030
    [No Abstract]   [Full Text] [Related]  

  • 5. Anosmia (smell failure) and dysgeusia (taste distortion) in COVID-19: it is genetic.
    Hendaus MA
    J Biomol Struct Dyn; 2023 Apr; 41(7):3162-3165. PubMed ID: 35147485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic.
    Krishnakumar HN; Momtaz DA; Sherwani A; Mhapankar A; Gonuguntla RK; Maleki A; Abbas A; Ghali AN; Al Afif A
    Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):505-509. PubMed ID: 36209486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?
    Alharbi H; You S; Katz J
    Oral Maxillofac Surg; 2022 Mar; 26(1):105-111. PubMed ID: 33954852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New loss of smell and taste: Uncommon symptoms in COVID-19 patients on Nord Franche-Comte cluster, France.
    Klopfenstein T; Zahra H; Kadiane-Oussou NJ; Lepiller Q; Royer PY; Toko L; Gendrin V; Zayet S
    Int J Infect Dis; 2020 Nov; 100():117-122. PubMed ID: 32771635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Anosmia Reporting Tool: Initial Findings.
    Kaye R; Chang CWD; Kazahaya K; Brereton J; Denneny JC
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):132-134. PubMed ID: 32340555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.
    Carignan A; Valiquette L; Grenier C; Musonera JB; Nkengurutse D; Marcil-Héguy A; Vettese K; Marcoux D; Valiquette C; Xiong WT; Fortier PH; Généreux M; Pépin J
    CMAJ; 2020 Jun; 192(26):E702-E707. PubMed ID: 32461325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can symptoms of anosmia and dysgeusia be diagnostic for COVID-19?
    Zahra SA; Iddawela S; Pillai K; Choudhury RY; Harky A
    Brain Behav; 2020 Nov; 10(11):e01839. PubMed ID: 32935915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Smell impairment in COVID-19 patients: mechanisms and clinical significance].
    Kryukov AI; Kazakova AA; Hecht AB
    Vestn Otorinolaringol; 2020; 85(5):93-97. PubMed ID: 33140943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nasal immunoglobulins in the recovery of olfactory function in COVID-19 patients.
    Vaira LA; Lechien JR; Salzano G; Maglitto F; Saussez S; De Riu G
    Am J Otolaryngol; 2022; 43(3):103301. PubMed ID: 34895763
    [No Abstract]   [Full Text] [Related]  

  • 14. Anosmia and dysgeusia amongst COVID-19 patients are associated with low levels of serum glucagon-like peptide 1.
    Ben-Chetrit E; Ben-Ya'acov A; Quitina A; Atia O; Regev E; Shteyer E; Nashef R
    Int J Clin Pract; 2021 Dec; 75(12):e14996. PubMed ID: 34714940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluticasone propionate suppresses the SARS-CoV-2 induced increase in respiratory epithelial permeability in vitro.
    Martens K; Vanhulle E; Viskens AS; Hellings PW; Vermeire K
    Rhinology; 2023 Apr; 61(2):161-169. PubMed ID: 36479866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of anosmia and dysgeusia in patients with mild SARS-CoV-2 infection.
    Levinson R; Elbaz M; Ben-Ami R; Shasha D; Levinson T; Choshen G; Petrov K; Gadoth A; Paran Y
    Infect Dis (Lond); 2020 Aug; 52(8):600-602. PubMed ID: 32552475
    [No Abstract]   [Full Text] [Related]  

  • 17. Does COVID-19 cause permanent damage to olfactory and gustatory function?
    Paolo G
    Med Hypotheses; 2020 Oct; 143():110086. PubMed ID: 32721795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and anosmia: A review based on up-to-date knowledge.
    Meng X; Deng Y; Dai Z; Meng Z
    Am J Otolaryngol; 2020; 41(5):102581. PubMed ID: 32563019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sudden onset anosmia and dysgeusia in two patients: An early sign of SARS-CoV-2 infection.
    Alamri A; Oriez C; Bouilloud F; Dupuy O; Ben Hamou A
    Presse Med; 2020 Apr; 49(1):104027. PubMed ID: 32447056
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 with and without anosmia or dysgeusia: A case-control study.
    Dev N; Sankar J; Gupta N; Meena RC; Singh C; Gupta DK; Sen MK
    J Med Virol; 2021 Apr; 93(4):2499-2504. PubMed ID: 33417259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.